Table 3.
Intake Group (n = 15) | Control Group (n = 15) | |||
---|---|---|---|---|
Pre | Post | Pre | Post | |
d-ROMs (U.CARR) | 270 ± 35 | 247 ± 25 ** | 249 (225–286) | 244 (225–292) |
BAP (µmol/L) | 2013 ± 149 | 2083 ± 150 | 2059 ± 142 | 2143 ± 140 |
BAP/d-ROMs ratio | 7.1 (6.9–8.2) | 8.7 (7.3–9.8) * | 8.1 ± 1.2 | 8.5 ± 1.4 |
CK (U/L) | 702 ± 398 † | 909 ± 605 | 330 (195–605) | 502 (323–857) |
LDH (U/L) | 244 (236–269) † | 253 (202–269) | 222 ± 40 | 237 ± 54 |
Values are mean ± SD or median (25–75 percentile). pre-intervention (Pre) vs post-intervention (Post). BAP/d-ROMs ratio and LDH in the Intake group and d-ROMs and CK in the Control group are paired t-test, others are Wilcoxon signed-rank test (* p < 0.05, ** p < 0.01). † indicates a significant difference as compared to the values of control group (p < 0.05). d-ROMs: diacron-reactive oxygen metabolites, BAP: biological antioxidant potential, CK: creatine kinase, LDH: lactate dehydrogenase.